Sidransky D - Search Results

1

Association between lifestyle factors and CpG island methylation in a cancer-free population.

Brait M, Ford JG, Papaiahgari S, Garza MA, Lee JI, Loyo M, Maldonado L, Begum S, McCaffrey L, Howerton M, Sidransky D, Emerson MR, Ahmed S, Williams CD, Hoque MO. Brait M, et al. Among authors: sidransky d. Cancer Epidemiol Biomarkers Prev. 2009 Nov;18(11):2984-91. doi: 10.1158/1055-9965.EPI-08-1245. Epub 2009 Oct 27. Cancer Epidemiol Biomarkers Prev. 2009. PMID: 19861513 Free PMC article.

2

A novel p16INK4A transcript.

Mao L, Merlo A, Bedi G, Shapiro GI, Edwards CD, Rollins BJ, Sidransky D. Mao L, et al. Among authors: sidransky d. Cancer Res. 1995 Jul 15;55(14):2995-7. Cancer Res. 1995. PMID: 7541708

3

Inactivation of the CDKN2/p16/MTS1 gene is frequently associated with aberrant DNA methylation in all common human cancers.

Herman JG, Merlo A, Mao L, Lapidus RG, Issa JP, Davidson NE, Sidransky D, Baylin SB. Herman JG, et al. Among authors: sidransky d. Cancer Res. 1995 Oct 15;55(20):4525-30. Cancer Res. 1995. PMID: 7553621

4

5' CpG island methylation is associated with transcriptional silencing of the tumour suppressor p16/CDKN2/MTS1 in human cancers.

Merlo A, Herman JG, Mao L, Lee DJ, Gabrielson E, Burger PC, Baylin SB, Sidransky D. Merlo A, et al. Among authors: sidransky d. Nat Med. 1995 Jul;1(7):686-92. doi: 10.1038/nm0795-686. Nat Med. 1995. PMID: 7585152

5

Localization of tumor suppressor loci on chromosome 9 in primary human renal cell carcinomas.

Cairns P, Tokino K, Eby Y, Sidransky D. Cairns P, et al. Among authors: sidransky d. Cancer Res. 1995 Jan 15;55(2):224-7. Cancer Res. 1995. PMID: 7812948

6

High frequency of p16 (CDKN2/MTS-1/INK4A) inactivation in head and neck squamous cell carcinoma.

Reed AL, Califano J, Cairns P, Westra WH, Jones RM, Koch W, Ahrendt S, Eby Y, Sewell D, Nawroz H, Bartek J, Sidransky D. Reed AL, et al. Among authors: sidransky d. Cancer Res. 1996 Aug 15;56(16):3630-3. Cancer Res. 1996. PMID: 8705996

7

p16 and p16 beta are potent growth suppressors of head and neck squamous carcinoma cells in vitro.

Liggett WH Jr, Sewell DA, Rocco J, Ahrendt SA, Koch W, Sidransky D. Liggett WH Jr, et al. Among authors: sidransky d. Cancer Res. 1996 Sep 15;56(18):4119-23. Cancer Res. 1996. PMID: 8797577

8

Deletional, mutational, and methylation analyses of CDKN2 (p16/MTS1) in primary and metastatic prostate cancer.

Jarrard DF, Bova GS, Ewing CM, Pin SS, Nguyen SH, Baylin SB, Cairns P, Sidransky D, Herman JG, Isaacs WB. Jarrard DF, et al. Among authors: sidransky d. Genes Chromosomes Cancer. 1997 Jun;19(2):90-6. Genes Chromosomes Cancer. 1997. PMID: 9171999

9

Role of the p16 tumor suppressor gene in cancer.

Liggett WH Jr, Sidransky D. Liggett WH Jr, et al. Among authors: sidransky d. J Clin Oncol. 1998 Mar;16(3):1197-206. doi: 10.1200/JCO.1998.16.3.1197. J Clin Oncol. 1998. PMID: 9508208 Review.

10

A comparison between microsatellite and quantitative PCR analyses to detect frequent p16 copy number changes in primary bladder tumors.

Cairns JP, Chiang PW, Ramamoorthy S, Kurnit DM, Sidransky D. Cairns JP, et al. Among authors: sidransky d. Clin Cancer Res. 1998 Feb;4(2):441-4. Clin Cancer Res. 1998. PMID: 9516934

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

591 results

Search Page

Filters